Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Eclipse Bioinnovations Inc. maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 4 pending office actions, which are distributed across 4 distinct art units. This distribution across art units indicates that the company's research and development efforts span several different specialized fields within the broader biotechnology sector.
The prosecution of these matters is handled by 4 distinct examiners, meaning each pending action is being reviewed by a different individual. BUNKER, AMY M is identified as the busiest examiner, currently managing 1 busiest examiner pending office action. Since each of the 4 distinct examiners is only handling 1 of the 4 pending office actions, the workload is perfectly distributed across the examining corps.
Practitioners managing this portfolio must navigate 4 distinct art units and 4 distinct examiners, requiring a versatile strategy. Because BUNKER, AMY M and the other three examiners each oversee only 1 pending office action, there is no single examiner who dominates the prosecution landscape. This diversity within Biotechnology & Pharmaceuticals requires the firm to adapt to four different sets of examiner expectations and art unit norms simultaneously.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §102 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BUNKER, AMY M | 1 | 29.1% | +45.5% |
| HILL, GRACELYN MARKHAM | 1 | 100.0% | +0.0% |
| JACKSON-TONGUE, LAKIA J | 1 | 69.0% | +20.8% |
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +54.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18173644 | METHODS FOR OLIGO TARGETED PROXIMITY LIGATION | HILL, GRACELYN MARKHAM | 42d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18148039 | METHODS FOR DETECTING RNA TRANSLATION | SWITZER, JULIET CAROLINE | 16d overdue |
| 18250423 | METHODS AND KITS FOR ENRICHING FOR POLYNUCLEOTIDES | BUNKER, AMY M | 11d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18148039 | METHODS FOR DETECTING RNA TRANSLATION | SWITZER, JULIET CAROLINE | 16d overdue |
| 18250423 | METHODS AND KITS FOR ENRICHING FOR POLYNUCLEOTIDES | BUNKER, AMY M | 11d overdue |
| 18148154 | METHODS FOR DETECTING RNA MODIFICATION TARGETS ON A GENE | JACKSON-TONGUE, LAKIA J | — |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| 1685 | 1 |
| 1645 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18250423 | METHODS AND KITS FOR ENRICHING FOR POLYNUCLEOTIDES | BUNKER, AMY M | 1684 | §103 | Final Rejection | 11d overdue | Pending | Apr 25, 2023 |
| 18173644 | METHODS FOR OLIGO TARGETED PROXIMITY LIGATION | HILL, GRACELYN MARKHAM | 1685 | §103 | Final Rejection | 42d overdue | Pending | Feb 23, 2023 |
| 18148154 | METHODS FOR DETECTING RNA MODIFICATION TARGETS ON A GENE | JACKSON-TONGUE, LAKIA J | 1645 | §102Other | Final Rejection | — | Pending | Dec 29, 2022 |
| 18148039 | METHODS FOR DETECTING RNA TRANSLATION | SWITZER, JULIET CAROLINE | 1682 | §103§112Other | Final Rejection | 16d overdue | Pending | Dec 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial